So pleased for my friend Mathai Mammen, founder Greg Verdine, and all of Parabilis Medicines on this remarkable milestone!
Parabilis Medicines said it would sell 33.5 million shares at $20 apiece, for a total of $670 million.
https://endpoints.news/parabilis-670m-ipo-sets-new-biotech-record-will-fund-cancer-drug/
More posts by Erik Lundh
Recent posts from Park Square Executive Search
